샘플 요청 목록

 카트 문의
시장보고서
상품코드
1511875

신경혈관 카테터 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 용도별, 최종 용도별, 지역별 부문별 예측(2024-2030년)

Neurovascular Catheters Market Size, Share & Trends Analysis Report By Type (Microcatheter, Balloon Catheter, Access Catheter, Embolization Catheter), By Applications, By End-use, And Regional Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경혈관 카테터 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 신경혈관 카테터 시장 규모는 2030년에 52억 3,000만 달러로 추계되며, 2024-2030년 CAGR 7.25%로 확대할 것으로 예측됩니다. 뇌졸중, 뇌동맥류, 뇌동맥 협착증과 같은 신경 질환의 유병률 증가가 시장 성장을 가속하고 있습니다. 세계뇌졸중기구(WSO)에 따르면 2022년에는 연간 1,220만 명 이상의 새로운 뇌졸중 환자가 발생할 것으로 예상되며, 25세 이상 성인 4명 중 1명은 평생 동안 뇌졸중을 앓게 될 것으로 예측됩니다. 또한 허혈성 뇌졸중은 매년 약 760만 명이 새롭게 발병합니다.

전 세계에서 발생하는 뇌졸중의 약 62%는 허혈성 뇌졸중이며, 매년 120만 건 이상의 지주막하 출혈이 새롭게 발생하고 있습니다. 따라서 가까운 미래에 신경혈관 카테터에 대한 수요가 증가할 것으로 예상됩니다. 선진국과 신흥 국가 모두에서 뇌동맥류 유병률이 증가함에 따라 기술적으로 진보된 제품 시장 도입이 더욱 촉진되고 있습니다. 예를 들어 2021년 9월 Medtronic plc는 Rist 079 Access Radial Guide Catheter와 Access Rist Radial Selective Catheter로 구성된 요골동맥 접근 포트폴리오에 대한 CE 마크 승인을 발표했습니다.

또한 2022년 3월, 마이크로포트 사이언티픽은 자사의 하이퍼플렉스 풍선 카테터가 일본 의약품의료기기종합기구(PMDA)로부터 등록 승인을 받았다고 발표했습니다. 뇌졸중 예방을 위해 세계 각국 정부는 다양한 노력을 기울이고 있습니다. 예를 들어 WISEWOMAN(Well-Integrated Screening and Evaluation for Women Across the Nation) 프로그램은 미국 CDC가 노스캐롤라, 매사추세츠, 애리조나 등 3개 주에서 시작한 프로그램입니다.에서 시작되었으며, 건강한 생활습관을 장려하여 여성의 뇌졸중 및 기타 신경혈관질환의 위험을 최소화하는 것을 목표로 합니다.

무료 샘플 사본 요청 또는 보고서 요약 보기: 신경혈관 카테터 시장 보고서

신경혈관 카테터 시장 보고서 하이라이트

2022년 뇌동맥류, 비출혈, 동정맥 기형 등 질환의 유병률 증가로 인해 색전 카테터가 27.62% 시장 점유율을 차지하며 신경혈관 카테터 시장을 장악했습니다.

용도별로는 경동맥 협착증, 죽상동맥경화증 등 신경혈관 질환 및 병증 환자가 증가함에 따라 뇌동맥류 분야가 2022년 32.79% 시장 점유율을 차지하며 독주했습니다.

최종 용도 중 병원은 2022년 시장에서 55.53%로 가장 큰 점유율을 차지할 것으로 예상됩니다. 수술, 치료 및 시술을 위해 입원하는 환자 증가는 가까운 미래에 신경혈관 카테터에 대한 수요를 증가시킬 것으로 예상됩니다.

북미가 2022년 33.23%의 최대 매출 점유율로 시장을 주도할 것으로 예상됩니다. 저침습 수술에 대한 수요 증가와 의료 인프라 개선을 위한 정부 구상 증가는 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한 기술 발전과 새로운 비침습적 시술의 혁신은 이 부문에 유리한 기회를 제공할 것으로 보입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 신경혈관 카테터 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 관련/보조 시장 전망
  • 시장 역학
    • 시장 촉진요인 분석
    • 시장 억제요인 분석
  • 신경혈관 카테터 시장 분석 툴
    • Porter's Five Forces 분석
    • PESTEL 분석

제4장 신경혈관 카테터 시장 : 유형 추정·동향 분석

  • 부문 대시보드
  • 세계의 신경혈관 카테터 시장 : 유형 변동 분석, 2023년 및 2030년
  • 세계의 신경혈관 카테터 시장 규모와 동향 분석, 유형별, 2018-2030년
  • 마이크로카테터
  • 풍선 카테터
  • 액세스 카테터
  • 색전카테터
  • 기타

제5장 신경혈관 카테터 시장 : 컴포넌트 추정·동향 분석

  • 부문 대시보드
  • 신경혈관 카테터 시장 : 컴포넌트의 변동 분석, 2023년 및 2030년
  • 세계의 신경혈관 카테터 시장 규모와 동향 분석, 컴포넌트별, 2018-2030년
  • 카테터 맨드릴
  • 카테터 라이너
  • 리플로우 열수축 튜브
  • 나일론 튜브/페박스
  • 기타 컴포넌트

제6장 신경혈관 카테터 시장 : 용도 추정·동향 분석

  • 부문 대시보드
  • 신경혈관 카테터 시장 : 용도 변동 분석, 2023년 및 2030년
  • 세계의 신경혈관 카테터 시장 규모와 동향 분석, 용도별, 2018-2030년
  • 색전성 뇌졸중
  • 뇌동맥류
  • 동정맥기형
  • 기타

제7장 신경혈관 카테터 시장 : 처방, 용도, 최종 용도별 지역 추정·동향 분석

  • 지역 대시보드
  • 시장 규모와 동향 분석, 2018-2030년
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제8장 경쟁 구도

  • 주요 시장 참여 기업별 최근 동향과 영향 분석
  • 기업 분류
  • 기업 시장 점유율 분석, 2023년
  • 기업 히트맵 분석
  • 전략 매핑
    • 확대
    • 합병과 인수
    • 파트너십과 협업
    • 신제품의 발매
    • 연구개발
    • 기업 개요
    • Medtronic
    • Nordson Corporation
    • Stryker Corporation
    • Terumo Corporation
    • Integer Holdings Corporation
    • Penumbra, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
KSA 24.07.16

Neurovascular Catheters Market Growth & Trends:

The global neurovascular catheters market size was estimated at USD 5.23 billion in 2030 and is projected to expand at a CAGR of 7.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving the growth of the market. According to the World Stroke Organization (WSO), in 2022, there will be over 12.2 million new strokes per year. One in every four adults over the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year.

Around 62% of all incident strokes worldwide are ischemic strokes, with over 1.2 million new subarachnoid hemorrhages occurring each year. Thus, this, in turn, is expected to increase the demand for neurovascular catheters in the near future. The rising prevalence of brain aneurysms in both developed and developing countries is further driving the introduction of technologically advanced products to the market. Market participants are constantly working to introduce technologically advanced products to the market.For instance, in September 2021, Medtronic plc announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter.

Furthermore, in March 2022, MicroPort Scientific Company announced that its Hyperflex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA). Various initiatives are undertaken by the government worldwide to prevent stroke. For instance, the Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program was started by the U.S. CDC in three states: North Carolina, Massachusetts, and Arizona, to minimize the risk of stroke and other neurovascular diseases in women by promoting a healthy lifestyle.

key Request a free sample copy or view report summary: Neurovascular Catheters Market Report

Neurovascular Catheters Market Report Highlights:

In 2022, embolization catheters dominated the neurovascular catheters market with a market share of 27.62% owing to the increasing prevalence of conditions, such as brain aneurysms, nose bleeding, and arteriovenous malformations.

Based on application, brain aneurysm segment dominated the market in 2022 with a market share of 32.79% owing to the rising number of patients suffering from neurovascular diseases and conditions, such as carotid artery stenosis and atherosclerosis.

Among end use, hospitals held a majority share of the market of 55.53% in the year 2022. An increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for neurovascular catheters in the near future.

North America led the market with a maximum revenue share of 33.23% in 2022. Rising demand for minimally invasive surgeries and rising government initiatives for improving healthcare infrastructures are among the key factors driving market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurovascular Catheters Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of hemorrhagic and ischemic stroke
      • 3.2.1.2. Increasing prevalence of brain aneurysm
      • 3.2.1.3. Shift toward minimally invasive neurosurgical procedures
      • 3.2.1.4. Increasing awareness about neurological conditions such as brain aneurysm and stroke
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Risks associated with the neurovascular catheters.
      • 3.2.2.2. High treatment cost associated with neurovascular disorders.
      • 3.2.2.3. Lack of infrastructure and medical professionals in underdeveloped economies to perform neurosurgery.
      • 3.2.2.4. Complex regulatory framework and lengthy product approval process
  • 3.3. Neurovascular Catheters Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Neurovascular Catheters Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Neurovascular Catheters Market: Type Movement Analysis, 2023 & 2030 (USD Million, Volume Unit)
  • 4.3. Global Neurovascular Catheters Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million, Volume Unit, Volume Unit)
  • 4.4. Microcatheter
    • 4.4.1. Microcatheter market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
  • 4.5. Balloon Catheter
    • 4.5.1. Balloon catheter market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.6. Access Catheter
    • 4.6.1. Access catheter market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.7. Embolization Catheter
    • 4.7.1. Embolization catheter market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
  • 4.8. Others
    • 4.8.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)

Chapter 5. Neurovascular Catheters Market: Component Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurovascular Catheters Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Global Neurovascular Catheters Market Size & Trend Analysis, by Component, 2018 to 2030 (USD Million)
  • 5.4. Catheter Mandrels
    • 5.4.1. Catheter mandrels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Catheter Liners
    • 5.5.1. Catheter liners market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.6. Reflow Heat Shrinks
    • 5.6.1. Reflow heat shrinks market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.7. Nylon Tubing/Pebax
    • 5.7.1. Nylon tubing/pebax market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Other Components
    • 5.8.1. Other components market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurovascular Catheters Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neurovascular Catheters Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Global Neurovascular Catheters Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Embolic Stroke
    • 6.4.1. Embolic stroke market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Brain Aneurysms
    • 6.5.1. Brain aneurysms market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 6.6. Arteriovenous Malformations
    • 6.6.1. Arteriovenous malformations market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neurovascular Catheters Market: Regional Estimates & Trend Analysis by Formulation, Application, & End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.K.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. U.K. neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait neurovascular catheters market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Medtronic
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Nordson Corporation
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Stryker Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Terumo Corporation
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Integer Holdings Corporation
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Penumbra, Inc.
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Johnson & Johnson Services, Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Integra LifeSciences Corporation
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제